CK1α overexpression correlates with poor survival in colorectal cancer
Abstract Background Colorectal cancer (CRC) is the fourth leading cause of cancer related deaths worldwide and prognosis in advanced tumor stage still remains poor. Since CK1 isoforms have been reported to be deregulated in several tumor entities CK1 has emerged as a novel drug target in cancer ther...
Main Authors: | Julia Richter, Anna-Laura Kretz, Johannes Lemke, Michael Fauler, Jens-Uwe Werner, Stephan Paschke, Frank Leithäuser, Doris Henne-Bruns, Andreas Hillenbrand, Uwe Knippschild |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4019-0 |
Similar Items
-
Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer
by: Xiao Shen, et al.
Published: (2023-03-01) -
CK1δ-Derived Peptides as Novel Tools Inhibiting the Interactions between CK1δ and APP695 to Modulate the Pathogenic Metabolism of APP
by: Aileen Roth, et al.
Published: (2021-06-01) -
TRAILblazing Strategies for Cancer Treatment
by: Anna-Laura Kretz, et al.
Published: (2019-03-01) -
Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy
by: Anna-Laura Kretz, et al.
Published: (2018-03-01) -
CK1 Is a Druggable Regulator of Microtubule Dynamics and Microtubule-Associated Processes
by: Aileen Roth, et al.
Published: (2022-03-01)